Drug application
VASOCIDIN (PREDNISOLONE SODIUM PHOSPHATE, SULFACETAMIDE SODIUM)
Drugs@FDA NDA 018988 · NOVARTIS
Key facts
| Drug name | VASOCIDIN |
|---|---|
| Active ingredients | PREDNISOLONE SODIUM PHOSPHATE, SULFACETAMIDE SODIUM |
| Application type | NDA |
| Application number | 018988 |
| Company | NOVARTIS |
| Dosage forms | SOLUTION/DROPS, OPHTHALMIC |
| Strength | EQ 0.23% PHOSPHATE;10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Aug 26, 1988 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.